NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
18.44
0.11 (0.60%)
At close: Jun 26, 2025, 3:59 PM
NewAmsterdam Pharma Revenue
NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a 257% growth. For the quarter ending March 31, 2025, NewAmsterdam Pharma generated $2.98M in revenue.
Revenue (ttm)
$45.56M
Revenue Growth
257%
Price / Sales Ratio
53.22
Revenue / Employee
$670.04K
Employees
68
Market Cap
2.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|